1-5 of 5
Robert Hermann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Enzastaurin in Patients with Follicular Lymphoma: Updated Final Clinical Results and Immunohistochemical Correlations

Lee Schwartzberg, MD, FACP, Robert Hermann, MD FACP, Ian W. Flinn, MD, PhD, Douglas Flora, MD, Eric D. Hsi, MD, Oday Hamid, Scott P. Myrand, BSc, MSc, MBA, Boris Lin, MD, PhD, Donald Thornton, MD, Peipei Shi, Ph.D., Tuan S Nguyen, Ph.D., Martin Dreyling
Journal: Blood
Blood (2012) 120 (21): 777.
https://doi.org/10.1182/blood.V120.21.777.777
Published: 2012
Journal Articles

Understanding United States (US) Treatment Practices for the Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: A US Subgroup Analysis of the WORLD CML Registry.

Robert Hermann, MD FACP, Carole B. Miller, MD, Rosalind Catchatorian, MD, David S. Snyder, MD, Solveig G. Ericson, MD, PhD, Oleg Zernovak, MD, Matthews A Juma, Jorge E. Cortes, MD
Journal: Blood
Blood (2012) 120 (21): 2781.
https://doi.org/10.1182/blood.V120.21.2781.2781
Published: 2012
Journal Articles

Final Results of a Single Arm Phase III Multicenter, Open-Label Study of Rituximab Administered by Faster Infusion in Patients with Previously Untreated Diffuse Large-B Cell (DLBCL) or Follicular Non-Hodgkin's Lymphoma (FL)

Shaker R. Dakhil, MD, Robert Hermann, MD, Akiko Chai, MS, Deborah Hurst, MD, Gregg Fine, MD, Paul Richards, MD
Journal: Blood
Blood (2011) 118 (21): 2703.
https://doi.org/10.1182/blood.V118.21.2703.2703
Published: 2011
Journal Articles

A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma

Bertrand Coiffier, MD, PhD, Evgenii Osmanov, MD, Xiaonan Hong, MD, Adriana Scheliga, MD, Jiri Mayer, MD, PhD, Fritz C Offner, MD, PhD, Simon A. Rule, MD, Adriana Teixeira, MD, Jan A Walewski, MD, PhD, DSc, Michael Crump, MD, FRCPC, Ofer Shpilberg, MD, MPH, Robert Hermann, MD, Sudha Parasuraman, MD, Eugene Zhu, PhD, Christopher Enny, BS, Panteli Theocharous, MSc, PhD, Helgi van de Velde, MD, PhD, Yusri Elsayed, MD, PhD, Pier Luigi Zinzani, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 857.
https://doi.org/10.1182/blood.V116.21.857.857
Published: 2010
Journal Articles

Rituximab Therapy after Response to R-CHOP Induction Therapy for Patients with Previously Untreated Indolent Non-Hodgkin’s Lymphoma (NHL): Clinical Outcomes and Pharmacokinetics (PK)

Louis Fehrenbacher, MD, Jonathan A. Polikoff, MD, Robert Hermann, MD, Haresh Jhangiani, MD, Jean Bjerke, MD, David Loeck, MD, Lowell Hart
Journal: Blood
Blood (2007) 110 (11): 1295.
https://doi.org/10.1182/blood.V110.11.1295.1295
Published: 2007